Virtu Financial, Inc. Class A VIRT 深 沪
等待开盘 04-02 09:30:00 美东时间
44.39
+0.410
+0.93%
华盛通- 最 高44.75
- 今 开44.28
- 成交量 82.59万股
- 最 低 44.00
- 昨 收 43.98
- 总市值 68.66亿
- 52周最高 45.0499
- 市盈率 静 8.65
- 换手率 0.53%
- 52周最低 31.31
- 委 比 -24.53%
- 总股本 1.55亿
- 历史最高 45.0499
- 量 比 1.12
- 振 幅 1.71%
- 历史最低 3.23
- 每 手 1
- 风险率 3.63%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 小摩、瑞穗等下调阿里目标价最低至164美元；达登饭店、联邦快递、林肯教育服务、Planet Labs等获多家大行上调目标价
今日重点评级关注：瑞穗：维持RELMADA THERAPEUTICS"跑赢大市"评级，目标价从10美元升至19美元；奥本海默：维持Pelthos Therapeutics"跑赢大市"评级，目标价从60美元升至62美元
03-23 13:53
Brent Hits $110, Rate-Hike Fears Hammer Stocks And Gold: What's Moving Markets Friday?
U.S. stocks fall to four-month lows as oil surges above $110, Treasury yields spike, and markets price a 50% chance of a Fed rate hike by October.
03-21 01:36
Piper Sandler Maintains Overweight on Virtu Finl, Raises Price Target to $61
Piper Sandler analyst Patrick Moley maintains Virtu Finl (NYSE:VIRT) with a Overweight and raises the price target from $57 to $61.
03-20 23:27
美股大行评级 | 苹果、SanDisk、西部数据、卡特彼勒、德克斯户外、霍尼韦尔、西南航空、万事达等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Praxis Precision Medicine"买入"评级，目标价从340美元升至1245美元；HC Wainwright & Co.：维持Perspective Therapeutics"买入"评级，目标价从10美元升至12美元
02-02 14:15
Goldman Sachs Maintains Neutral on Virtu Finl, Raises Price Target to $40
Goldman Sachs analyst Alexander Blostein maintains Virtu Finl (NYSE:VIRT) with a Neutral and raises the price target from $36 to $40.
01-31 01:54
财报速睇 | Virtu Financial, Inc. Class A 2025财年Q4营收9.70亿美元，同比增长16.3%；归母净利润1.40亿美元，同比增长48.7%
华盛资讯1月30日讯，Virtu Financial, Inc. Class A公布2025财年Q4业绩，公司Q4营收9.70亿美元，同比增长16.3%，归母净利润1.40亿美元，同比增长48.7%。
01-30 01:55
Virtu Financial shares are trading higher after the company reported better-than-expected Q4 financial results.
Virtu Financial shares are trading higher after the company reported better-tha...
01-29 21:56
Virtu Finl Earnings Review: Q4 Summary
Virtu Finl (NYSE:VIRT) just disclosed its Q4 earnings on Thursday, January 29, ...
01-29 20:08
Earnings Scheduled For January 29, 2026
Companies Reporting Before The Bell • MOGU (NYSE:MOGU) is estimated to report e...
01-29 19:11
美股大行评级 | 潜在涨幅258.31%！Tempest Therapeutics获HC Wainwright上调评级至"买入"，目标价11美元
今日重点评级关注：HC Wainwright & Co.：上调Tempest Therapeutics评级至"买入"，目标价11美元；Guggenheim：维持Sportradar Gr"买入"评级，目标价从34美元升至35美元
01-23 19:46
